Levadex is an inhaler that delivers a dose of the classic migraine treatment medication DHE (dihydroergotamine). The FDA has questions about the manufacturing process used for parts of the inhaler device. Specifically, they want to know how the aerosol cans of the drug are filled.
In their public response, MAP Pharma executes emphasized the FDA concerns did not relate to the efficacy or safety of Levadex. Research released in 2010 demonstrated the product was effective at alleviating the main symptoms of a migraine attack: pain, sensitivity to sound and light and nausea.
Inhaled DHE Levadex for Migraine Treatment
Inhaled DHE Levadex Effective at Treating Migraines
MAP Confident in Levadex, Plans Swift Response to FDA
Map Says Rejected Migraine Drug Doesn't Have Safety Issue
Subscribe to the Somebody Heal Me feed: Subscribe in a reader or subscribe by e-mail. Follow me on Twitter @somebodyhealme.
Content by Diana E. Lee.DISCLAIMER: Nothing on this site constitutes medical or legal advice. I am a patient who is engaged and educated and enjoys sharing my experiences and news about migraines, pain and depression. Please consult your own health care providers for advice on your unique situation.